INmune Bio Inc (INMB)
8.07
-0.35
(-4.16%)
USD |
NASDAQ |
Jul 02, 16:00
8.06
-0.01
(-0.12%)
After-Hours: 20:00
INmune Bio Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | -15.00M |
March 31, 2021 |
Date | Value |
---|---|
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-15.00M
Minimum
Jun 2021
--
Maximum
Jun 2020
-2.50M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
AVITA Medical Inc | 15.07M |
Xeris Biopharma Holdings Inc | -19.65M |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 1.00M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -7.476M |
Cash from Financing (Quarterly) | -2.50M |
Free Cash Flow | -18.32M |
Free Cash Flow Per Share (Quarterly) | -0.4147 |
Free Cash Flow to Equity (Quarterly) | -5.01M |
Free Cash Flow Yield | -12.61% |